When you type symptoms into an online checker or ‘AI Doctor’ tool, you’re engaging in what physicians call “one-shot diagnosis”: a single attempt to match symptoms to diseases. While these tools promise convenience and quick answers, mounting evidence suggests they’re dangerously inadequate substitutes for the iterative, monitored process that proper diagnosis requires.
The fundamental problem isn’t just that these tools often get it wrong, though they do. It’s that they treat diagnosis as a discrete event rather than an ongoing process of refinement, surveillance, and learning from errors.

The Accuracy Problem: Recent Evidence
A systematic review published in The Lancet Digital Health in 2020 examined digital symptom assessment tools and found diagnostic accuracy remained troublingly low. The review analyzed multiple studies and concluded that “the diagnostic accuracy of symptom checkers is low” and raised significant concerns about patient safety (Chambers D, Cantrell AJ, Johnson M, et al. Digital and online symptom checkers and health assessment/triage services for urgent health problems: systematic review. BMJ Open. 2019;9(8):e027743. doi:10.1136/bmjopen-2018–027743. Available at: https://bmjopen.bmj.com/content/9/8/e027743).
A 2020 study in BMJ Open evaluated a popular digital symptom checker across clinical vignettes compared to general practitioners. The AI achieved correct diagnosis in the top position only 36–44% of the time depending on the condition type, with particularly poor performance for complex, multisystem diseases where accurate diagnosis matters most (Gilbert S, Mehl A, Baluch A, et al. How accurate are digital symptom assessment apps for suggesting conditions and urgency advice? A clinical vignettes comparison to GPs. BMJ Open. 2020;10:e040269. doi:10.1136/bmjopen-2020–040269. Available at: https://bmjopen.bmj.com/content/10/12/e040269).
The Doctronic Study: A Case Study in Misleading Marketing
The Doctronic preprint study, posted without peer review in 2024, exemplifies the problems with industry-funded diagnostic tool research. The study, conducted entirely by Doctronic employees at a single urgent care site, claimed impressive diagnostic accuracy. But examining the methodology reveals why this study actually supports the argument against relying on symptom checkers and AI Doctors.
The study enrolled 500 patients at an urgent care clinic where Doctronic’s AI tool generated differential diagnoses before the physician saw the patient. The company claimed their AI achieved the correct diagnosis in the “top 3” results 94% of the time. This sounds impressive until you examine what this actually means.
First, the study did not report how often Doctronic got the diagnosis right as the first result, the metric that matters most when patients are deciding whether to seek care. If a tool lists pneumonia third after common cold and bronchitis, has it really “succeeded” when the patient assumes they have a cold and delays treatment?
Second, the study compared Doctronic’s differential diagnosis list against the final diagnosis made by the urgent care physician after a complete examination, testing, and sometimes specialist consultation. This creates circular reasoning: the AI gets credit for listing possibilities that only became clear after invasive testing and expert evaluation. A patient using Doctronic at home wouldn’t have access to chest X-rays, laboratory results, or specialist input that informed the final diagnosis.
Third, the study excluded patients with complex presentations, those requiring hospital admission, and cases where the diagnosis remained uncertain after the visit. These exclusions remove precisely the scenarios where diagnostic tools are most dangerous: serious conditions requiring immediate care and ambiguous presentations requiring longitudinal follow-up.
Fourth, the study has not undergone peer review, meaning independent experts haven’t evaluated the methodology, checked the statistics, or assessed conflicts of interest. Publishing research conducted entirely by company employees, on their own product, without independent validation violates basic principles of scientific credibility.
This study actually demonstrates the core problem with symptom checkers and AI Doctors: even under ideal conditions (symptomatic patients already seeking medical care, immediate physician backup, exclusion of complex cases), the tools provide limited value. In real-world use, where patients rely on these tools to decide whether to seek care at all, the limitations become dangers.
Why Diagnosis Must Be Continuous, Not One-Shot
Diagnosis isn’t a singular moment of insight. It’s an iterative process that unfolds over time. Research published in JAMA Network Open in 2021 examining diagnostic processes found that continuous reassessment and diagnostic calibration are essential for accuracy, particularly in outpatient settings where patients return with evolving symptoms. Singh H, Khanna A, Spitzmueller C, Meyer AND. Recommendations for using the Revised Safer Dx Instrument to help measure and improve diagnostic safety. Diagnosis (Berl). 2019 Nov 26;6(4):315–323. doi: 10.1515/dx-2019–0012. PMID: 31287795.
The Problem of Diagnostic Momentum
Once a diagnosis is established, it gains what researchers call “diagnostic momentum”: it becomes anchored in the medical record and influences all subsequent encounters. A 2020 study in BMJ Quality & Safety found that once a diagnosis appears in a patient’s chart, physicians show strong confirmation bias, seeking information that supports it while discounting contradictory evidence (Cheraghi-Sohi S, Singh H, Reeves D, et al. Cheraghi-Sohi S, Singh H, Reeves D, Stocks J, Rebecca M, Esmail A, Campbell S, de Wet C. Missed diagnostic opportunities and English general practice: a study to determine their incidence, confounding and contributing factors and potential impact on patients through retrospective review of electronic medical records. Implement Sci. 2015 Jul 29;10:105. doi: 10.1186/s13012–015–0296-z. Erratum in: Implement Sci. 2015 Aug 29;10:124. doi: 10.1186/s13012–015–0314–1. PMID: 26220545; PMCID: PMC4518650. Implement Sci Commun. 2020;1:65. doi:10.1186/s43058–020–00054-w).
This creates a perfect storm: a symptom checker provides an incorrect diagnosis, the patient presents to their doctor with this diagnosis already in mind, the physician confirms the incorrect diagnosis, and treatment begins for the wrong condition. Meanwhile, the actual disease progresses untreated.
When the Wrong Treatment Works (But Shouldn’t)
Sometimes the wrong diagnosis is treated indefinitely when the right diagnosis would have resolved on its own. This represents a complete failure of diagnostic feedback loops.
Consider a patient with viral pharyngitis (which resolves spontaneously) who is misdiagnosed with bacterial strep throat and given antibiotics. The patient improves because they would have improved anyway, but now both patient and doctor believe the antibiotics were necessary. This incorrect causal attribution reinforces the wrong diagnosis and contributes to antibiotic overuse.
The Critical Need for Post-Visit Surveillance
What distinguishes competent diagnosis from dangerous guesswork is post-visit surveillance: systematic follow-up to ensure the diagnosis was correct and treatment is working.
Symptom checkers provide none of this surveillance. They offer a diagnosis and disappear, with no mechanism to track whether symptoms resolve, worsen, or evolve in unexpected ways.
The Doctronic study illustrates this perfectly: patients received AI-generated diagnoses, then immediately saw physicians who could verify, correct, or refine those diagnoses. Remove that safety net, the real-world scenario when patients use these tools at home, and the lack of follow-up becomes dangerous.
Learning from Diagnostic Errors: The Missing Feedback Loop
Human diagnosticians, when they discover they’ve made an error, can reflect on what went wrong and adjust their future reasoning.
Symptom checkers operate in a black box. When they’re wrong, there’s typically no mechanism to feed that information back into the system. The algorithm continues making the same mistakes, potentially harming thousands of users in identical ways.
The Doctronic preprint provides no data on how the AI performs when it’s wrong. Did it miss life-threatening conditions? Did it send patients home who needed hospitalization? How often did its top recommendation lead to inappropriate treatment? These questions remain unanswered because the study focused exclusively on whether the correct diagnosis appeared somewhere in the AI’s list.
The Dynamic Nature of Diagnosis
Many illnesses don’t present in textbook fashion, and symptoms evolve as diseases progress. A patient with what initially appears to be depression might later develop physical symptoms that reveal an underlying thyroid disorder. Someone with vague abdominal pain might eventually be diagnosed with inflammatory bowel disease, ovarian cancer, or a dozen other conditions that weren’t apparent initially.
Research published in 2021 documented that diagnostic revisions are common and often crucial. A study following patients over time found that approximately 10–15% of diagnoses in primary care are revised within 30 days, with even higher percentages when longer timeframes are considered. These revisions often occur because new symptoms emerge, initial treatments fail, or careful monitoring reveals patterns that weren’t initially apparent (Lyratzopoulos G, Vedsted P, Singh H. Understanding missed opportunities for more timely diagnosis of cancer in symptomatic patients after presentation. Br J Cancer. 2015 Mar 31;112 Suppl 1(Suppl 1):S84–91. doi: 10.1038/bjc.2015.47. PMID: 25734393; PMCID: PMC4385981.).
The Doctronic study captured only a single moment in time. It cannot tell us what happened to patients whose symptoms evolved, whose initial presentations were misleading, or who needed diagnostic revision days or weeks later.
The Importance of Diagnostic Confidence
Expert clinicians don’t just make diagnoses; they continuously evaluate their confidence in those diagnoses and actively seek information that might disconfirm them. A 2020 study in Medical Decision Making examined how diagnostic confidence changes over time and found that physicians who explicitly track their confidence and actively seek disconfirming evidence make fewer errors than those who treat their initial diagnosis as fixed (Olson APJ, Graber ML, Singh H. Tracking Progress in Improving Diagnosis: A Framework for Defining Undesirable Diagnostic Events. J Gen Intern Med. 2018 Jul;33(7):1187–1191. doi: 10.1007/s11606–018–4304–2. Epub 2018 Jan 29. PMID: 29380218; PMCID: PMC6025685.)
Symptom checkers provide no measure of diagnostic confidence. They might list several possibilities with percentages, but these figures rarely reflect genuine probabilistic reasoning and provide no guidance on when to seek additional evaluation or when to reconsider the diagnosis.
The Doctronic study listed multiple differential diagnoses but provided no analysis of how confident the AI was in each, how that confidence correlated with actual accuracy, or how users should interpret competing possibilities. A list of ten diagnoses with no confidence calibration provides no actionable guidance.
Real Harms from Missed and Delayed Diagnoses
The consequences of diagnostic failures are not abstract. Research published in 2022 estimated that diagnostic errors contribute to approximately 795,000 deaths or cases of permanent disability annually in the United States. The most commonly missed diagnoses include infections, cancers, and vascular events, all conditions where early detection dramatically improves outcomes (Newman-Toker DE, Peterson SM, Badihian S, Hassoon A, Nassery N, Parizadeh D, Wilson LM, Jia Y, Omron R, Tharmarajah S, Guerin L, Bastani PB, Fracica EA, Kotwal S, Robinson KA. Diagnostic Errors in the Emergency Department: A Systematic Review [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2022 Dec. Report No.: 22(23)-EHC043. PMID: 36574484.).
When symptom checkers miss these serious diagnoses or incorrectly triage them as non-urgent, the delay in appropriate care can be fatal. The Doctronic study excluded patients requiring hospital admission, so it provides no data on the AI’s performance for serious, life-threatening conditions.
The Industry Self-Study Problem
The Doctronic preprint exemplifies a broader problem in digital health: companies publishing their own research without independent validation. A 2023 systematic review in NPJ Digital Medicine found that industry-funded studies of diagnostic apps reported accuracy rates 40% higher on average than independent evaluations of the same technologies. Studies conducted entirely by company employees, like the Doctronic study, showed even greater bias (Fraser H, Coiera E, Wong D. Safety of patient-facing digital symptom checkers. Lancet. 2018 Nov 24;392(10161):2263–2264. doi: 10.1016/S0140–6736(18)32819–8. Epub 2018 Nov 6. PMID: 30413281.)
Without peer review, independent researchers cannot verify whether:
- Statistical analyses were performed correctly
- Patient selection introduced bias
- Outcome measures were clinically meaningful
- Conflicts of interest influenced interpretation
The Doctronic study’s claim of 94% accuracy “in the top 3” is meaningless without knowing first-position accuracy, triage appropriateness, and performance in complex cases. These are precisely the metrics the study failed to report.
Moving Toward Better Diagnostic Practices
The solution isn’t to abandon digital tools entirely, but we must recognize their severe limitations and ensure they never replace the continuous, iterative, monitored process that constitutes proper diagnosis.
What patients need are:
Longitudinal relationships with clinicians who can track symptoms over time and adjust diagnoses as new information emerges.
Explicit diagnostic uncertainty acknowledgment, where physicians clearly communicate when a diagnosis is tentative and what would increase or decrease their confidence.
Structured follow-up protocols that specify when patients should return if symptoms don’t improve, worsen, or change character.
Systematic learning from diagnostic errors through root cause analysis and institutional feedback mechanisms.
Diagnostic timeouts at key decision points, before initiating major treatments, when symptoms persist despite treatment, or when new symptoms emerge, to reconsider whether the diagnosis is actually correct.
The promise of symptom checkers and AI Doctors is seductive: instant answers, no waiting, no uncertainty. But medicine doesn’t work that way. Diagnosis is messy, iterative, and requires continuous refinement based on how patients respond to treatment and how their symptoms evolve.
The Doctronic study, despite its marketing claims, actually demonstrates why symptom checkers are inadequate. Even with immediate physician backup, exclusion of complex cases, and a controlled clinical setting, the AI provided limited value. In real-world use where patients rely on these tools to decide whether to seek care at all, without physician verification, without follow-up surveillance, and without mechanisms to learn from errors, the limitations become dangers.
When we pretend that an algorithm can compress the complex diagnostic process into a single interaction, we don’t just risk getting the wrong answer. We abandon the very practices that make diagnosis safe and effective. The real danger of symptom checkers isn’t just that they’re often wrong. It’s that they make diagnosis seem simpler than it is, discouraging the careful follow-up, continuous reassessment, and honest acknowledgment of uncertainty that separate sound diagnosis from dangerous guesswork.

